ArticleBMC cardiovascular disorders2026
Prevalence of right ventricular dysfunction and its echocardiographic predictors in patients with heart failure with preserved ejection fraction: a retrospective cohort study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine right ventricular dysfunction (RVD) prevalence in patients with heart failure and preserved ejection fraction (HFpEF); to systematically evaluate predictive values of echocardiographic parameters for RVD.
methodsA total of 163 patients diagnosed with HFpEF between January 2022 and January 2024 were retrospectively analyzed. All patients underwent assessment of right ventricular function. RVD was characterized by the presence of either a tricuspid annular plane systolic excursion (TAPSE) below 17 mm or a right ventricular free wall strain (RV-FWS) absolute value under 20%. Baseline clinical characteristics and echocardiographic parameters were collected, including left atrial volume index (LAVI), mean ratio of early mitral inflow velocity to early diastolic mitral annular velocity (mean E/e'), systolic pulmonary artery pressure (sPAP), and right ventricular fractional area change (FAC).
resultsThe prevalence of RVD among patients with HFpEF was 41.7% (68/163). The RVD group was characterized by substantially higher NT-proBNP levels. Echocardiographic measures including RV-FWS, sPAP, mean E/e', LAVI, TAPSE, and FAC independently predicted the occurrence of RVD. Among individual parameters, RV-FWS showed the best predictive performance. The combined predictive model incorporating the six aforementioned parameters exhibited excellent discriminatory ability. After internal validation using the bootstrap method, the corrected AUC was 0.989.
conclusionsRV-FWS and sPAP are the strongest independent echocardiographic predictors of RVD. An integrated assessment strategy combining multiparametric echocardiography with NT-proBNP measurement may substantially improve risk stratification of RVD in HFpEF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.